Alpha1-Proteinase Inhibitor (Human), is a sterile, stable, lyophilized preparation of highly purified human alpha1-proteinase inhibitor (A1-PI) The global market for Human Alpha1-Proteinase Inhibitor was estimated to be worth US$ 218 million in 2023 and is…
Author: QYResearch
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 6 countries (include United States, Germany, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Coagulation Factor VIIa Market Expansion Report 2024: Effective Strategies and Market Expansion
Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade. The global market…
C1 Esterase Inhibitor Market Comprehensive Report 2024: Size, Growth Prospects, and Regional Analysis
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood. The global market for C1 Esterase Inhibitor was estimated to be worth US$ 128.6 million in 2023 and…
Anti-Inhibitor Coagulant Complex Market Growth in 2024-2030: Dynamics, Opportunities, and Strategies
Anti-inhibitor coagulant complex, also known as FEIBA (factor eight inhibitor bypassing activity), contains several proteins involved in the prothrombinase complex. The global market for Anti-Inhibitor Coagulant Complex was estimated to be worth US$ 51 million…
Recombinant Antihemophilic Factor Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Recombinant antihemophilic factor works by temporarily raising levels of factor VIII in the blood to aid in clotting. The global market for Recombinant Antihemophilic Factor was estimated to be worth US$ 2152 million in 2023…
Caspofungin Acetate for Injection Market Development Strategy Report 2024: Expanding Reach and Impact
Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: Empirical therapy for presumed fungal infections in febrile, neutropenic patients….
Pulmonary Arterial Hypertension Treatment Market Detailed Analysis 2024: Market Size, Future Prospects, and Industry Trends
Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle…
Direct Renin Inhibitors (DRIs) Market Expansion Analysis Report: Identifying Opportunities and Implementing Strategies
Direct renin inhibition is a new means for blocking the renin–angiotensin system at the rate-limiting step of the cascade of events triggered by renin release—the interaction of renin with its physiological substrate…
Cervical Artificial Discs Market Strategies for Expansion Analysis Report: Opportunities and Challenges Ahead
Cervical Artificial Discs are technological devices that are designed to replace natural discs in the cervical spine (the neck) that has degenerated and become the source of persistent pain that has not…
Chronic Obstructive Pulmonary Disease Drugs Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. The global market for Chronic Obstructive Pulmonary Disease Drugs was estimated to…